BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17353095)

  • 21. Involvement of cholesterol in the pathogenesis of Alzheimer's disease: role of statins.
    Pregelj P
    Psychiatr Danub; 2008 Jun; 20(2):162-7. PubMed ID: 18587285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome.
    Lee JH; Chulikavit M; Pang D; Zigman WB; Silverman W; Schupf N
    Neurosci Lett; 2007 Sep; 425(2):105-9. PubMed ID: 17826910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis.
    Zhou B; Teramukai S; Fukushima M
    Dement Geriatr Cogn Disord; 2007; 23(3):194-201. PubMed ID: 17259710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down syndrome, Alzheimer's disease and seizures.
    Menéndez M
    Brain Dev; 2005 Jun; 27(4):246-52. PubMed ID: 15862185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholesterol, statins, and dementia: what the cardiologist should know.
    Wanamaker BL; Swiger KJ; Blumenthal RS; Martin SS
    Clin Cardiol; 2015 Apr; 38(4):243-50. PubMed ID: 25869997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of HMG-CoA reductase inhibitors on cognition in patients with Alzheimer's dementia: a prospective withdrawal and rechallenge pilot study.
    Padala KP; Padala PR; McNeilly DP; Geske JA; Sullivan DH; Potter JF
    Am J Geriatr Pharmacother; 2012 Oct; 10(5):296-302. PubMed ID: 22921881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low cholesterol, statins and outcomes in patients with first-ever acute ischemic stroke.
    Koton S; Molshatzki N; Bornstein NM; Tanne D
    Cerebrovasc Dis; 2012; 34(3):213-20. PubMed ID: 23006641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic potential of statins in Alzheimer's disease.
    Kandiah N; Feldman HH
    J Neurol Sci; 2009 Aug; 283(1-2):230-4. PubMed ID: 19321181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's disease, cholesterol, and statins: the junctions of important metabolic pathways.
    Silva T; Teixeira J; Remião F; Borges F
    Angew Chem Int Ed Engl; 2013 Jan; 52(4):1110-21. PubMed ID: 23280829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.
    Li G; Larson EB; Sonnen JA; Shofer JB; Petrie EC; Schantz A; Peskind ER; Raskind MA; Breitner JC; Montine TJ
    Neurology; 2007 Aug; 69(9):878-85. PubMed ID: 17724290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease.
    Chang CH; Lee YC; Tsai CT; Chang SN; Chung YH; Lin MS; Lin JW; Lai MS
    Atherosclerosis; 2014 Jan; 232(1):224-30. PubMed ID: 24401243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do statins slow down Alzheimer's disease? A review.
    Caballero J; Nahata M
    J Clin Pharm Ther; 2004 Jun; 29(3):209-13. PubMed ID: 15153082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effects.
    Miida T; Takahashi A; Ikeuchi T
    Pharmacol Ther; 2007 Feb; 113(2):378-93. PubMed ID: 17113151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statins: the role in the treatment and prevention of Alzheimer's neurodegeneration.
    Pac-Soo C; Lloyd DG; Vizcaychipi MP; Ma D
    J Alzheimers Dis; 2011; 27(1):1-10. PubMed ID: 21734347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of cholesterol in Alzheimer's neuro-pathogenesis].
    Biondi E
    Riv Biol; 2006; 99(2):210-5. PubMed ID: 17115369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial.
    Cooper SA; Caslake M; Evans J; Hassiotis A; Jahoda A; McConnachie A; Morrison J; Ring H; Starr J; Stiles C; Sullivan F
    Trials; 2014 Jun; 15():202. PubMed ID: 24888381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer's disease in subjects with Down syndrome.
    Patel A; Rees SD; Kelly MA; Bain SC; Barnett AH; Thalitaya D; Prasher VP
    Neurosci Lett; 2011 Jan; 487(2):144-8. PubMed ID: 20946940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The road to LOAD: late-onset Alzheimer's disease and a possible way to block it.
    Whitfield JF
    Expert Opin Ther Targets; 2007 Oct; 11(10):1257-60. PubMed ID: 17907956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can statins prevent dementia in older adults?
    Haan MN
    J Am Geriatr Soc; 2010 Jul; 58(7):1393-4. PubMed ID: 20649690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.